Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Jaguar Health Inc (NQ: JAGX ) 4.030 -0.080 (-1.95%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Jaguar Health Inc < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Dow Falls Over 100 Points; Sea Posts Upbeat Sales March 04, 2024 U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Monday. Following the market opening Monday, the Dow traded down 0.34% to 38,951.34 while the NASDAQ fell... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Pre-Market Session March 04, 2024 Via Benzinga Why BioVie Shares Are Trading Lower By Around 42%; Here Are 20 Stocks Moving Premarket March 04, 2024 Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public offering. BioVie shares dipped 41.8% to $1.10 in pre-market trading Here are... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday March 04, 2024 We're starting off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday morning! Via InvestorPlace Jaguar Health Requests and Receives Hearing on Nasdaq Listing Compliance February 23, 2024 Via ACCESSWIRE Jaguar Health Announces Submission of Orphan Drug Designation Application to the FDA for Crofelemer for Cholera-Related Diarrhea February 12, 2024 Via ACCESSWIRE Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session March 01, 2024 Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. Via Benzinga What In The World Is Going On With Jaguar Health (JAGX) Stock? March 01, 2024 Jaguar Health shares are trading higher by 53.7% Friday. The company last Friday provided an update on its listing status with the Nasdaq Stock Market. Via Benzinga Jaguar Health Announces FDA Agrees with Clinical Trial Protocol for Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs February 15, 2024 Via ACCESSWIRE Issuance of New US Patent Bolsters IP Protection for Jaguar Health in the Treatment of Congenital Diarrheal Disorders (CDDs) January 04, 2024 Via ACCESSWIRE FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea in Dogs December 04, 2023 Via ACCESSWIRE Jaguar Health to Present December 5 at the MedInvest Oncology Investor Conference November 30, 2023 Via ACCESSWIRE Jaguar Health Donates Supply of Mytesi to Humanitarian Aid Organization Direct Relief February 14, 2024 Via ACCESSWIRE 'Rainforests Are Nature's Medicine Cabinets': Biotech Co. Performs Fresh Research On Traditional Plants For Modern Mental Health Challenges January 30, 2024 Via Benzinga Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Study Indicates Psychoactive Activity of Medicinal Plant Utilized for Centuries by Indigenous Peoples in Tropical Regions January 30, 2024 Via ACCESSWIRE Jaguar Health to Present January 31 at The Microcap Conference and Participate in a Fireside Chat February 1 at the Lytham Partners Investor Select Conference January 29, 2024 Via ACCESSWIRE Why Tellurian Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket January 26, 2024 Shares of Tellurian Inc. (NASDAQ: TELL) shares rose sharply in pre-market trading following a report suggesting the company hired Lazard to explore a possible sale. Tellurian shares jumped 16.3% to... Via Benzinga Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 26, 2024 Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter. Via Benzinga Dog Study Published in PLOS ONE Shows Statistically Significant Results for Use of Jaguar Health’s Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea (CTD) January 25, 2024 Via ACCESSWIRE Why United Airlines Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket January 23, 2024 Shares of United Airlines Holdings, Inc. (NASDAQ: UAL) shares rose in today’s pre-market trading as the company reported better-than-expected financial results for its fourth quarter. Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session January 18, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session January 12, 2024 Via Benzinga Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) January 05, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 13, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session December 11, 2023 Via Benzinga A Majority of Subjects in Jaguar Health's Placebo-Controlled Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Chose to Continue on to Stage II December 11, 2023 Via ACCESSWIRE MASCC (Multinational Association of Supportive Care in Cancer) Webinar on GI Toxicities from Cancer Therapies Made Possible by Grant From Napo Pharmaceuticals, a Jaguar Health Family Company December 07, 2023 Via ACCESSWIRE Study Data on Quality of Life for Breast Cancer Patients and Survivors, Supported by Napo Pharmaceuticals (a Jaguar Health Family Company), Published on San Antonio Breast Cancer Symposium (SABCS) Website December 06, 2023 Via ACCESSWIRE Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session November 21, 2023 Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the... Via Benzinga Top Line Data for Jaguar Health’s Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Forthcoming November 21, 2023 Via ACCESSWIRE < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.